These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
4. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [TBL] [Abstract][Full Text] [Related]
5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
6. The resumption of consumption -- a review on tuberculosis. Ducati RG; Ruffino-Netto A; Basso LA; Santos DS Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):697-714. PubMed ID: 17160276 [TBL] [Abstract][Full Text] [Related]
7. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Vernon A; Burman W; Benator D; Khan A; Bozeman L Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410 [TBL] [Abstract][Full Text] [Related]
8. Tuberculosis and human immunodeficiency virus infection in developing countries. Harries AD Lancet; 1990 Feb; 335(8686):387-90. PubMed ID: 1968123 [TBL] [Abstract][Full Text] [Related]
9. [Immunology of tuberculosis and current status of vaccine development]. Ulrichs T Pneumologie; 2008 Mar; 62(3):143-7. PubMed ID: 18320494 [TBL] [Abstract][Full Text] [Related]
10. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. De Cock KM; Chaisson RE Int J Tuberc Lung Dis; 1999 Jun; 3(6):457-65. PubMed ID: 10383056 [TBL] [Abstract][Full Text] [Related]
12. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Colebunders R; Bastian I Int J Tuberc Lung Dis; 2000 Feb; 4(2):97-107. PubMed ID: 10694086 [TBL] [Abstract][Full Text] [Related]
13. [Update on the epidemiology, diagnosis and therapy of tuberculosis in HIV-infected patients]. Saleeb PG; Buchwald UK Pneumologie; 2014 Oct; 68(10):666-75. PubMed ID: 25290921 [TBL] [Abstract][Full Text] [Related]
14. Challenges of tuberculosis control. Murray S CMAJ; 2006 Jan; 174(1):33-4. PubMed ID: 16389233 [No Abstract] [Full Text] [Related]
15. [Prospects for development of new antituberculous drugs]. Tomioka H Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850 [TBL] [Abstract][Full Text] [Related]
16. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162 [TBL] [Abstract][Full Text] [Related]
17. The tuberculosis X factor. Lancet Infect Dis; 2006 Nov; 6(11):679. PubMed ID: 17067912 [No Abstract] [Full Text] [Related]
18. Rifapentine for the treatment of pulmonary tuberculosis. Munsiff SS; Kambili C; Ahuja SD Clin Infect Dis; 2006 Dec; 43(11):1468-75. PubMed ID: 17083024 [TBL] [Abstract][Full Text] [Related]